I am Yoshinori Kagawa, MD, PhD, Deputy Director of Gastroenterological Surgery, Chief of Colorectal Surgery, and Director of the Rectal Cancer Center at Osaka International Cancer Institute, Japan. I am a colorectal surgeon-scientist dedicated to improving survival, organ preservation, postoperative function, and quality of life for patients with colorectal cancer through the integration of surgery, chemotherapy, radiotherapy, molecular diagnostics, and multidisciplinary team-based care, and I believe my work is distinguished by its balance of scientific rigor, clinical practicality, and patient-centered decision-making. I have built my academic career around locally advanced rectal cancer, total neoadjuvant therapy, non-operative management, robotic and minimally invasive surgery, and ctDNA-guided precision oncology, and I have authored numerous peer-reviewed articles as first author, corresponding author, or co-author, delivered presentations at national and international academic meetings, and contributed to the field through invited educational activities, leadership roles, and sustained participation in professional societies including the Japanese Society of Gastroenterological Surgery, the Japan Society of Coloproctology, the Japan Society for Endoscopic Surgery, and related academic organizations. I also serve the academic community through peer review, editorial contributions, and scholarly commentary, with a strong interest in translating emerging evidence into safe and practical strategies that can improve real-world care for patients with colon and rectal cancer. I have been recognized as an invited faculty member at Osaka University and as one of Best Doctors in Japan, and I continue to pursue collaborative clinical and translational research that connects high-quality surgery with better systemic therapy, biomarker development, and individualized treatment selection. I seek to build a long-term research platform that advances precision colorectal cancer care by combining minimally invasive surgery, total neoadjuvant therapy, organ preservation, molecular residual disease assessment, and AI-assisted prediction while also strengthening education, regional collaboration, and high-reliability clinical systems. I bring strong active listening, communication, interpersonal, leadership, mentoring, management, and problem-solving skills, and I value the ability to guide multidisciplinary teams, train young surgeons, standardize complex procedures, and make timely decisions in high-stakes clinical settings. I also enjoy medical education, public health outreach, walking, and activities that help me reflect, recharge, and stay connected to people beyond the operating room.